ccRCC is uniquely suited for this exploitation since the majority (more than 80%) of ccRCC harbor VHL mutation, which conveys distinct characteristics on tumor cells and drives tumor development via HIF (either HIF-1α or HIF-2α) stabilization27, 29, 30. Here, EPAS1 is linked to neoplasm.